EP1847549A3 (en )2008-01-16 Papillomavirus polyprotein constructs AU6117696A (en )1996-12-30 Nucleic acid respiratory syncytial virus vaccines WO2001034801A3 (en )2002-01-31 Recombinant gelatin in vaccines IL134392A0 (en )2001-04-30 Vaccine against hpv SG152917A1 (en )2009-06-29 Neisseria meningitidis antigens GB2303854B (en )1998-10-21 Helicobacter proteins and vaccines DK0757717T3 (en )2006-09-25 papillomavirus vaccines WO1993001210A3 (en )1993-04-15 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) EP1420821B8 (en )2011-02-02 Immunologically significant herpes simplex virus antigens and methods for using same CA2042236A1 (en )1991-11-11 Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 AU2002309259A1 (en )2003-11-11 Improved polysaccharide and glycoconjugate vaccines_____________ MX9603182A (en )1997-05-31 Hepatitis b vaccine. WO2003011331A3 (en )2003-09-25 Materials and methods relating to improved vaccination strategies DK0892054T3 (en )2007-04-02 Clostridium perfringens vaccine NZ515041A (en )2004-03-26 Nucleic acid immunization EP0957936A4 (en )2001-09-12 Formulations of recombinant papillomavirus vaccines HU9200583D0 (en )1992-05-28 Method for producing el peptides of rubeola NZ334582A (en )2000-07-28 Polyprotein construct of a papillomavirus AU8405798A (en )1999-02-10 A swine hepatitis e virus and uses thereof AU8156594A (en )1995-03-09 Non-A non-B sequences WO2002060390A3 (en )2002-10-03 Induction of immune responses to isoaspartyl-modified antigens WO2002000250A3 (en )2002-10-31 Hiv-1 vaccines and screening methods therefor ES2012815A6 (en )1990-04-16 Vaccine against melanoma WO2001043769A3 (en )2001-12-27 Antigen delivery WO1994014967A3 (en )1994-09-29 Cs31a protein capsule subunit modified by at least one heterologous peptide, cs31a protein capsule comprising said subunit, micro-organisms having such subunits on their outer membrane, and methods for preparing and using same